|
UBE2D4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.635300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.023640E-02 |
| Normal-vs-Stage2 |
2.662800E-01 |
| Normal-vs-Stage3 |
1.74645999999612E-05 |
| Normal-vs-Stage4 |
4.399500E-03 |
| Stage1-vs-Stage2 |
8.833600E-01 |
| Stage1-vs-Stage3 |
6.077600E-03 |
| Stage1-vs-Stage4 |
1.475420E-01 |
| Stage2-vs-Stage3 |
4.172300E-02 |
| Stage2-vs-Stage4 |
1.338810E-01 |
| Stage3-vs-Stage4 |
9.977400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.235000E-04 |
| Normal-vs-AfricanAmerican |
4.878100E-02 |
| Normal-vs-Asian |
1.546030E-01 |
| Caucasian-vs-AfricanAmerican |
8.812800E-01 |
| Caucasian-vs-Asian |
2.851000E-01 |
| AfricanAmerican-vs-Asian |
3.687400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.782700E-04 |
| Normal-vs-Female |
8.760100E-03 |
| Male-vs-Female |
5.434000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.481300E-03 |
| Normal-vs-Extreme_Weight |
3.878000E-03 |
| Normal-vs-Obese |
4.573700E-04 |
| Normal-vs-Extreme_Obese |
6.064200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.083400E-01 |
| Normal_Weight-vs-Obese |
6.327600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.685900E-02 |
| Extreme_Weight-vs-Obese |
6.001400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.219600E-02 |
| Obese-vs-Extreme_Obese |
1.334160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.770100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.717600E-02 |
| Normal-vs-Age(61-80Yrs) |
8.041800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.250000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.301000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.894800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.793600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.884800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.598760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.766800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.325800E-02 |
| Normal-VS-Type2 PRCC |
1.204300E-03 |
| Normal-VS-KIRP CIMP |
3.53009999010112E-09 |
| Normal-VS-Unclassified PRCC |
2.878800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.325700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.62579999999957E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.313800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.353880E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.565400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.802600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.393100E-04 |
| Normal-vs-N1 |
2.07760000003887E-06 |
| Normal-vs-N2 |
1.60227999999041E-05 |
| N0-vs-N1 |
1.995430E-01 |
| N0-vs-N2 |
2.943000E-01 |
| N1-vs-N2 |
5.344400E-01 |
|
|
